TGF-β inhibition combined with cytotoxic nanomedicine normalizes triple negative breast cancer microenvironment towards anti-tumor immunity.
Panagi M, Voutouri C, Mpekris F, Papageorgis P, Martin MR, Martin JD, Demetriou P, Pierides C, Polydorou C, Stylianou A, Louca M, Koumas L, Costeas P, Kataoka K, Cabral H, Stylianopoulos T.
Panagi M, et al. Among authors: voutouri c.
Theranostics. 2020 Jan 12;10(4):1910-1922. doi: 10.7150/thno.36936. eCollection 2020.
Theranostics. 2020.
PMID: 32042344
Free PMC article.